Advertisement

Medicaid Unwinding Linked to Disruption of Chronic Medication Therapy in Youth

0

Pausing Medicaid eligibility determinations during COVID-19 pandemic linked to increased risk for having no prescriptions and cash-pay prescriptions

Custom Gene Editing Helps Baby With Rare Condition

0
By I. Edwards HealthDay Reporter FRIDAY, May 16, 2025 (HealthDay News) — A baby born with a rare and deadly genetic disease is the world's...

Novo Nordisk, U.S. Biotech Company Team Up to Create Obesity Pills

0
By I. Edwards HealthDay Reporter FRIDAY, May 16, 2025 (HealthDay News) — Danish drugmaker Novo Nordisk is teaming up with California-based biotech Septerna to develop...

Lecanemab for Alzheimer Disease Safe, Feasible in Real-World Practice

0

Patients in the earliest stage of Alzheimer disease, with very mild symptoms, experienced the lowest risk of complications

Risk of Obesity-Related Cancer Similar for GLP-1 Receptor Agonists and Bariatric Surgery

0

Findings for matched groups of patients with obesity and diabetes taking first-generation GLP-1 RA or undergoing bariatric metabolic surgery

Gabapentinoids Not Directly Associated With Risk of Self-Harm

0

However, increased risk of self-harm is seen before initiation of treatment, during initial phase of treatment, and after discontinuation

No Link Found Between COVID-19 Vaccination During Pregnancy and Spontaneous Abortion

0

Authors say findings confirm safety of COVID-19 vaccine during pregnancy

NIH Research Cuts Leave Cancer Patient Facing Hard Choice

0
By I. Edwards HealthDay Reporter THURSDAY, May 15, 2025 (HealthDay News) — A mother with stage 4 colon cancer faces an uncertain future after federal...

HHS, FDA Begin ‘Operation Stork Speed’ to Improve Quality of Infant Formula

0

Agencies say significant progress has already been made; input has been requested from the public

Mortality Up With Loss of Low-Income Subsidy for Drugs

0

Mortality difference amplified for users of medications for cardiovascular disease, chronic lung disease, HIV